Quality of life during lung cancer treatment with immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how patients with advanced lung cancer feel during their treatment, which combines chemotherapy, radiation, and an immunotherapy drug. The goal is to understand and improve quality of life during therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer that has spread locally but not to distant organs.
- You are 18 years old or older.
- You are scheduled to receive chemotherapy, radiation, and an immunotherapy drug for about 12 months.
- You are able to take part in daily activities despite your health (for example, able to care for yourself).
- You do not have another serious illness or health condition that could interfere with the study results.
- You are able to read and understand Swedish to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with advanced non-small cell lung cancer who received immunotherapy (immune checkpoint inhibitors) alone or in combination with other treatments. It aims to understand why some patients survive longer than others by analyzing their medical data and using AI to predict outcomes.
This study looks at how immunotherapy affects the quality of life of cancer patients who also have diabetes. It aims to understand and improve their overall well-being during treatment.
This study aims to understand the care needs of people with lung cancer who are receiving or have received immunotherapy. By participating, you can help improve support for other patients going through similar treatment.
This study tests a combination of chemotherapy and immunotherapy in people with advanced non-small cell lung cancer that has spread or cannot be removed with surgery. The goal is to see how well this treatment works in patients with different levels of daily activity.
This study uses a computer program (machine learning) to predict how lung cancer immunotherapy affects your quality of life. It aims to help doctors better support you during treatment by identifying problems early.
This study is a survey to learn about the experiences and feelings of people with non-small cell lung cancer who are taking immunotherapy drugs. The goal is to understand how you're doing on treatment, which can help improve care for others.
Hear when a new Non-Small Cell Carcinoma of Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.